Smith & Nephew plc (SNNUF)
OTC
Closed
Aug 21, 2026
Day's Range
15.4852 wk Range
13.10Overview - SNNUF - Smith & Nephew plc
Key Statistics
Valuation
Enterprise Value
16.20B
P/E (Trailing)
‪20.91‬
P/E (Forward)
‪15.17‬
PEG Ratio
‪-18.93‬
Price / Sales (TTM)
‪2.05‬
Price / Book
‪2.54‬
EV / EBITDA
‪11.72‬
Profitability
Gross Margin
‪75.26%‬
Profit Margin
‪10.07%‬
Operating Margin
‪14.46%‬
Return on Assets
‪5.15%‬
Return on Equity
‪11.85%‬
Ownership
Shares Outstanding
849.36M
Float
841.90M
Held by Insiders
‪0.23%‬
Held by Institutions
‪75.95%‬
Price stats
Beta
‪0.68‬
50-Day Avg
‪14.37‬
200-Day Avg
‪15.67‬
Dividends
Payout Ratio
‪53.20%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SNNUF - Smith & Nephew plc
Peers - SNNUF - Smith & Nephew plc
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
Profile Summary - SNNUF - Smith & Nephew plc
About
Smith & Nephew plc is a British multinational medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Headquartered in Watford, England, it develops and manufactures advanced products across three core business units: Advanced Wound Management for treating chronic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
